{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T00:59:48Z","timestamp":1792976388088,"version":"4.5.0"},"reference-count":139,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,6,2]],"date-time":"2025-06-02T00:00:00Z","timestamp":1748822400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,6,2]],"date-time":"2025-06-02T00:00:00Z","timestamp":1748822400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100012401","name":"Beijing Science and Technology Planning Project","doi-asserted-by":"publisher","award":["D161100005116003"],"award-info":[{"award-number":["D161100005116003"]}],"id":[{"id":"10.13039\/501100012401","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005902","name":"Institute for Clinical and Translational Research, University of Wisconsin, Madison","doi-asserted-by":"publisher","award":["HLTCMHPP2023125"],"award-info":[{"award-number":["HLTCMHPP2023125"]}],"id":[{"id":"10.13039\/100005902","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Transl Med"],"DOI":"10.1186\/s12967-025-06519-x","type":"journal-article","created":{"date-parts":[[2025,6,2]],"date-time":"2025-06-02T13:15:12Z","timestamp":1748870112000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":22,"title":["Macrophages in prostate cancer: dual roles in tumor progression and immune evasion"],"prefix":"10.1186","volume":"23","author":[{"ORCID":"https:\/\/orcid.org\/0009-0004-6135-4221","authenticated-orcid":false,"given":"Ruihong","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianxin","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yilei","family":"Liao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yinuo","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peiqi","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziqiang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Han","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingling","family":"Lai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,6,2]]},"reference":[{"key":"6519_CR1","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21763","author":"F Bray","year":"2024","unstructured":"Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2024. https:\/\/doi.org\/10.3322\/caac.21763.","journal-title":"CA Cancer J Clin"},{"issue":"17\u201318","key":"6519_CR2","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.1101\/gad.315739.118","volume":"32","author":"G Wang","year":"2018","unstructured":"Wang G, Zhao D, Spring DJ, DePinho RA. Genetics and biology of prostate cancer. Genes Dev. 2018;32(17\u201318):1105\u201340. https:\/\/doi.org\/10.1101\/gad.315739.118.","journal-title":"Genes Dev"},{"issue":"328","key":"6519_CR3","doi-asserted-by":"publisher","first-page":"328rv4","DOI":"10.1126\/scitranslmed.aad7118","volume":"8","author":"W Zou","year":"2016","unstructured":"Zou W, Wolchok JD, Chen L. PD-L1 (B7-H1) and PD-1 pathway Blockade for cancer therapy: mechanisms, response biomarkers, and combinations. Sci Transl Med. 2016;8(328):328rv4. https:\/\/doi.org\/10.1126\/scitranslmed.aad7118.","journal-title":"Sci Transl Med"},{"issue":"8","key":"6519_CR4","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1038\/s41568-020-0267-9","volume":"20","author":"JS De Bono","year":"2020","unstructured":"De Bono JS, Guo C, Gurel B, et al. Prostate carcinogenesis: inflammatory storms. Nat Rev Cancer. 2020;20(8):455\u201369. https:\/\/doi.org\/10.1038\/s41568-020-0267-9.","journal-title":"Nat Rev Cancer"},{"issue":"3","key":"6519_CR5","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1002\/pros.23738","volume":"79","author":"TE Krueger","year":"2019","unstructured":"Krueger TE, Thorek DLJ, Meeker AK, Isaacs JT, Brennen WN. Tumor-infiltrating mesenchymal stem cells: drivers of the immunosuppressive tumor microenvironment in prostate cancer? Prostate. 2019;79(3):320\u201330. https:\/\/doi.org\/10.1002\/pros.23738.","journal-title":"Prostate"},{"issue":"22","key":"6519_CR6","doi-asserted-by":"publisher","first-page":"6764","DOI":"10.1158\/1078-0432.CCR-17-0019","volume":"23","author":"M Bilusic","year":"2017","unstructured":"Bilusic M, Madan RA, Gulley JL. Immunotherapy of prostate cancer: facts and hopes. Clin Cancer Res. 2017;23(22):6764\u201370. https:\/\/doi.org\/10.1158\/1078-0432.CCR-17-0019.","journal-title":"Clin Cancer Res"},{"issue":"9","key":"6519_CR7","doi-asserted-by":"publisher","first-page":"1664","DOI":"10.1016\/j.ejca.2009.02.015","volume":"45","author":"K Ebelt","year":"2009","unstructured":"Ebelt K, Babaryka G, Frankenberger B, et al. Prostate cancer lesions are surrounded by FOXP3+, PD-1\u2009+\u2009and B7-H1\u2009+\u2009lymphocyte clusters. Eur J Cancer. 2009;45(9):1664\u201372. https:\/\/doi.org\/10.1016\/j.ejca.2009.02.015.","journal-title":"Eur J Cancer"},{"issue":"10","key":"6519_CR8","doi-asserted-by":"publisher","first-page":"1949","DOI":"10.1084\/jem.20101956","volume":"208","author":"B Molon","year":"2011","unstructured":"Molon B, Ugel S, Del Pozzo F, et al. Chemokine nitration prevents intratumoral infiltration of antigen-specific T cells. J Exp Med. 2011;208(10):1949\u201362. https:\/\/doi.org\/10.1084\/jem.20101956.","journal-title":"J Exp Med"},{"issue":"6230","key":"6519_CR9","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1126\/science.aaa6204","volume":"348","author":"JA Joyce","year":"2015","unstructured":"Joyce JA, Fearon DT. T cell exclusion, immune privilege, and the tumor microenvironment. Science. 2015;348(6230):74\u201380. https:\/\/doi.org\/10.1126\/science.aaa6204.","journal-title":"Science"},{"issue":"1","key":"6519_CR10","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1186\/1471-2407-13-258","volume":"13","author":"H Yuan","year":"2013","unstructured":"Yuan H, Hsiao YH, Zhang Y, et al. Destructive impact of T-lymphocytes, NK and mast cells on basal cell layers: implications for tumor invasion. BMC Cancer. 2013;13(1):258. https:\/\/doi.org\/10.1186\/1471-2407-13-258.","journal-title":"BMC Cancer"},{"issue":"4","key":"6519_CR11","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1007\/s10555-014-9502-8","volume":"33","author":"MT Schweizer","year":"2014","unstructured":"Schweizer MT, Drake CG. Immunotherapy for prostate cancer: recent developments and future challenges. Cancer Metastasis Rev. 2014;33(4):641\u201355. https:\/\/doi.org\/10.1007\/s10555-014-9502-8.","journal-title":"Cancer Metastasis Rev"},{"issue":"11","key":"6519_CR12","doi-asserted-by":"publisher","first-page":"3254","DOI":"10.1158\/1078-0432.CCR-07-5164","volume":"14","author":"KS Sfanos","year":"2008","unstructured":"Sfanos KS, Bruno TC, Maris CH, et al. Phenotypic analysis of prostate-infiltrating lymphocytes reveals TH17 and Treg skewing. Clin Cancer Res. 2008;14(11):3254\u201361. https:\/\/doi.org\/10.1158\/1078-0432.CCR-07-5164.","journal-title":"Clin Cancer Res"},{"issue":"15","key":"6519_CR13","doi-asserted-by":"publisher","first-page":"1694","DOI":"10.1002\/pros.21009","volume":"69","author":"KS Sfanos","year":"2009","unstructured":"Sfanos KS, Bruno TC, Meeker AK, De Marzo AM, Isaacs WB, Drake CG. Human prostate-infiltrating CD8\u2009+\u2009T lymphocytes are oligoclonal and PD-1+. Prostate. 2009;69(15):1694\u2013703. https:\/\/doi.org\/10.1002\/pros.21009.","journal-title":"Prostate"},{"issue":"3","key":"6519_CR14","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1189\/jlb.5VMR1116-477RR","volume":"102","author":"Z Lopez-Bujanda","year":"2017","unstructured":"Lopez-Bujanda Z, Drake CG. Myeloid-derived cells in prostate cancer progression: phenotype and prospective therapies. J Leukoc Biol. 2017;102(3):393\u2013406. https:\/\/doi.org\/10.1189\/jlb.5VMR1116-477RR.","journal-title":"J Leukoc Biol"},{"issue":"7","key":"6519_CR15","doi-asserted-by":"publisher","first-page":"e1016700","DOI":"10.1080\/2162402X.2015.1016700","volume":"4","author":"AA Wu","year":"2015","unstructured":"Wu AA, Drake V, Huang HS, Chiu S, Zheng L. Reprogramming the tumor microenvironment: Tumor-induced immunosuppressive factors paralyze T cells. Oncoimmunology. 2015;4(7):e1016700. https:\/\/doi.org\/10.1080\/2162402X.2015.1016700.","journal-title":"Oncoimmunology"},{"key":"6519_CR16","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.coi.2016.01.004","volume":"39","author":"DH Munn","year":"2016","unstructured":"Munn DH, Bronte V. Immune suppressive mechanisms in the tumor microenvironment. Curr Opin Immunol. 2016;39:1\u20136. https:\/\/doi.org\/10.1016\/j.coi.2016.01.004.","journal-title":"Curr Opin Immunol"},{"issue":"3","key":"6519_CR17","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1016\/j.ccell.2023.02.016","volume":"41","author":"KE De Visser","year":"2023","unstructured":"De Visser KE, Joyce JA. The evolving tumor microenvironment: from cancer initiation to metastatic outgrowth. Cancer Cell. 2023;41(3):374\u2013403. https:\/\/doi.org\/10.1016\/j.ccell.2023.02.016.","journal-title":"Cancer Cell"},{"issue":"4","key":"6519_CR18","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1038\/s41577-021-00542-x","volume":"22","author":"M Philip","year":"2022","unstructured":"Philip M, Schietinger A. CD8(+) T cell differentiation and dysfunction in cancer. Nat Rev Immunol. 2022;22(4):209\u201323. https:\/\/doi.org\/10.1038\/s41577-021-00542-x.","journal-title":"Nat Rev Immunol"},{"issue":"6574","key":"6519_CR19","doi-asserted-by":"publisher","first-page":"abe6474","DOI":"10.1126\/science.abe6474","volume":"374","author":"L Zheng","year":"2021","unstructured":"Zheng L, Qin S, Si W, et al. Pan-cancer single-cell landscape of tumor-infiltrating T cells. Science. 2021;374(6574):abe6474. https:\/\/doi.org\/10.1126\/science.abe6474.","journal-title":"Science"},{"issue":"4","key":"6519_CR20","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1038\/s41568-019-0235-4","volume":"20","author":"AM Van der Leun","year":"2020","unstructured":"Van der Leun AM, Thommen DS, Schumacher TN. CD8(+) T cell States in human cancer: insights from single-cell analysis. Nat Rev Cancer. 2020;20(4):218\u201332. https:\/\/doi.org\/10.1038\/s41568-019-0235-4.","journal-title":"Nat Rev Cancer"},{"issue":"5","key":"6519_CR21","doi-asserted-by":"publisher","first-page":"1022","DOI":"10.1016\/j.cell.2018.01.004","volume":"172","author":"JP B\u00f6ttcher","year":"2018","unstructured":"B\u00f6ttcher JP, Bonavita E, Chakravarty P, et al. NK cells stimulate recruitment of cDC1 into the tumor microenvironment promoting cancer immune control. Cell. 2018;172(5):1022\u2013e103714. https:\/\/doi.org\/10.1016\/j.cell.2018.01.004.","journal-title":"Cell"},{"issue":"4","key":"6519_CR22","doi-asserted-by":"publisher","first-page":"750","DOI":"10.1016\/j.cell.2017.04.01","volume":"169","author":"Y Lavin","year":"2017","unstructured":"Lavin Y, Kobayashi S, Leader A, et al. Innate immune landscape in early lung adenocarcinoma by paired single-cell analyses. Cell. 2017;169(4):750\u2013e76517. https:\/\/doi.org\/10.1016\/j.cell.2017.04.01.","journal-title":"Cell"},{"key":"6519_CR23","doi-asserted-by":"publisher","first-page":"1295257","DOI":"10.3389\/fimmu.2023.1295257","volume":"14","author":"U Basak","year":"2023","unstructured":"Basak U, Sarkar T, Mukherjee S, et al. Tumor-associated macrophages: an effective player of the tumor microenvironment. Front Immunol. 2023;14:1295257. https:\/\/doi.org\/10.3389\/fimmu.2023.1295257.","journal-title":"Front Immunol"},{"issue":"1","key":"6519_CR24","doi-asserted-by":"publisher","first-page":"2398195","DOI":"10.1080\/07853890.2024.2398195","volume":"56","author":"Y Ou","year":"2024","unstructured":"Ou Y, Xia C, Ye C, et al. Comprehensive scRNA-seq analysis to identify new markers of M2 macrophages for predicting the prognosis of prostate cancer. Ann Med. 2024;56(1):2398195. https:\/\/doi.org\/10.1080\/07853890.2024.2398195.","journal-title":"Ann Med"},{"issue":"1","key":"6519_CR25","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1038\/nrurol.2017.167","volume":"15","author":"KS Sfanos","year":"2018","unstructured":"Sfanos KS, Yegnasubramanian S, Nelson WG, De Marzo AM. The inflammatory microenvironment and Microbiome in prostate cancer development. Nat Rev Urol. 2018;15(1):11\u201324. https:\/\/doi.org\/10.1038\/nrurol.2017.167.","journal-title":"Nat Rev Urol"},{"issue":"8","key":"6519_CR26","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1158\/1940-6207.CAPR-15-0090","volume":"8","author":"KS Sfanos","year":"2015","unstructured":"Sfanos KS, Canene-Adams K, Hempel H, et al. Bacterial prostatitis enhances 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP)-induced cancer at multiple sites. Cancer Prev Res (Phila). 2015;8(8):683\u201392. https:\/\/doi.org\/10.1158\/1940-6207.CAPR-15-0090.","journal-title":"Cancer Prev Res (Phila)"},{"issue":"16","key":"6519_CR27","doi-asserted-by":"publisher","first-page":"2877","DOI":"10.1002\/cncr.32167","volume":"125","author":"BA Dickerman","year":"2019","unstructured":"Dickerman BA, Torfadottir JE, Valdimarsdottir UA, et al. Body fat distribution on computed tomography imaging and prostate cancer risk and mortality in the AGES-Reykjavik study. Cancer. 2019;125(16):2877\u201385. https:\/\/doi.org\/10.1002\/cncr.32167.","journal-title":"Cancer"},{"issue":"3","key":"6519_CR28","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1016\/j.juro.2015.06.023","volume":"194","author":"A Atala","year":"2015","unstructured":"Atala A, Re. A human prostatic bacterial isolate alters the prostatic microenvironment and accelerates prostate cancer progression. J Urol. 2015;194(3):849. https:\/\/doi.org\/10.1016\/j.juro.2015.06.023.","journal-title":"J Urol"},{"issue":"1","key":"6519_CR29","doi-asserted-by":"publisher","first-page":"e0169984","DOI":"10.1371\/journal.pone.0169984","volume":"12","author":"T Kakegawa","year":"2017","unstructured":"Kakegawa T, Bae Y, Ito T, et al. Frequency of Propionibacterium acnes infection in prostate glands with negative biopsy results is an independent risk factor for prostate cancer in patients with increased serum PSA titers. PLoS ONE. 2017;12(1):e0169984. https:\/\/doi.org\/10.1371\/journal.pone.0169984.","journal-title":"PLoS ONE"},{"issue":"12","key":"6519_CR30","doi-asserted-by":"publisher","first-page":"758","DOI":"10.1016\/j.trecan.2016.10.016","volume":"2","author":"L Schito","year":"2016","unstructured":"Schito L, Semenza GL. Hypoxia-inducible factors: master regulators of cancer progression. Trends Cancer. 2016;2(12):758\u201370. https:\/\/doi.org\/10.1016\/j.trecan.2016.10.016.","journal-title":"Trends Cancer"},{"issue":"7","key":"6519_CR31","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1056\/NEJMra0910283","volume":"364","author":"HK Eltzschig","year":"2011","unstructured":"Eltzschig HK, Carmeliet P. Hypoxia and inflammation. N Engl J Med. 2011;364(7):656\u201365. https:\/\/doi.org\/10.1056\/NEJMra0910283.","journal-title":"N Engl J Med"},{"issue":"10","key":"6519_CR32","doi-asserted-by":"publisher","first-page":"3716","DOI":"10.1172\/JCI84433","volume":"126","author":"CT Taylor","year":"2016","unstructured":"Taylor CT, Doherty G, Fallon PG, Cummins EP. Hypoxia-dependent regulation of inflammatory pathways in immune cells. J Clin Invest. 2016;126(10):3716\u201324. https:\/\/doi.org\/10.1172\/JCI84433.","journal-title":"J Clin Invest"},{"key":"6519_CR33","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.semcancer.2017.03.001","volume":"43","author":"V Huber","year":"2017","unstructured":"Huber V, Camisaschi C, Berzi A, et al. Cancer acidity: an ultimate frontier of tumor immune escape and a novel target of Immunomodulation. Semin Cancer Biol. 2017;43:74\u201389. https:\/\/doi.org\/10.1016\/j.semcancer.2017.03.001.","journal-title":"Semin Cancer Biol"},{"issue":"2","key":"6519_CR34","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.trecan.2018.10.010","volume":"5","author":"C Prunier","year":"2019","unstructured":"Prunier C, Baker D, Ten Dijke P, Ritsma L. TGF-\u03b2 family signaling pathways in cellular dormancy. Trends Cancer. 2019;5(2):66\u201378. https:\/\/doi.org\/10.1016\/j.trecan.2018.10.010.","journal-title":"Trends Cancer"},{"issue":"4","key":"6519_CR35","doi-asserted-by":"publisher","first-page":"924","DOI":"10.1016\/j.immuni.2019.03.024","volume":"50","author":"E Batlle","year":"2019","unstructured":"Batlle E, Massagu\u00e9 J. Transforming growth factor-\u03b2 signaling in immunity and cancer. Immunity. 2019;50(4):924\u201340. https:\/\/doi.org\/10.1016\/j.immuni.2019.03.024.","journal-title":"Immunity"},{"issue":"6","key":"6519_CR36","doi-asserted-by":"publisher","first-page":"1985","DOI":"10.1016\/S0002-9440(10)65517-4","volume":"155","author":"AM De Marzo","year":"1999","unstructured":"De Marzo AM, Marchi VL, Epstein JI, Nelson WG. Proliferative inflammatory atrophy of the prostate: implications for prostatic carcinogenesis. Am J Pathol. 1999;155(6):1985\u201392. https:\/\/doi.org\/10.1016\/S0002-9440(10)65517-4.","journal-title":"Am J Pathol"},{"issue":"5","key":"6519_CR37","doi-asserted-by":"publisher","first-page":"828","DOI":"10.1016\/S0090-4295(00)00776-7","volume":"56","author":"MJ Putzi","year":"2000","unstructured":"Putzi MJ, De Marzo AM. Morphologic transitions between proliferative inflammatory atrophy and high-grade prostatic intraepithelial neoplasia. Urology. 2000;56(5):828\u201332. https:\/\/doi.org\/10.1016\/S0090-4295(00)00776-7.","journal-title":"Urology"},{"issue":"13","key":"6519_CR38","doi-asserted-by":"publisher","first-page":"1378","DOI":"10.1002\/pros.20992","volume":"69","author":"W Wang","year":"2009","unstructured":"Wang W, Bergh A, Damber JE. Morphological transition of proliferative inflammatory atrophy to high-grade intraepithelial neoplasia and cancer in human prostate. Prostate. 2009;69(13):1378\u201386. https:\/\/doi.org\/10.1002\/pros.20992.","journal-title":"Prostate"},{"key":"6519_CR39","doi-asserted-by":"publisher","first-page":"1269624","DOI":"10.1155\/2020\/1269624","volume":"2020","author":"C Han","year":"2020","unstructured":"Han C, Wang Z, Xu Y, et al. Roles of reactive oxygen species in biological behaviors of prostate cancer. Biomed Res Int. 2020;2020:1269624. https:\/\/doi.org\/10.1155\/2020\/1269624.","journal-title":"Biomed Res Int"},{"issue":"10","key":"6519_CR40","doi-asserted-by":"publisher","first-page":"2214","DOI":"10.3390\/ijms18102214","volume":"18","author":"Y Miyata","year":"2017","unstructured":"Miyata Y, Matsuo T, Sagara Y, Ohba K, Ohyama K, Sakai H. A mini-review of reactive oxygen species in urological cancer: correlation with NADPH oxidases, angiogenesis, and apoptosis. Int J Mol Sci. 2017;18(10):2214. https:\/\/doi.org\/10.3390\/ijms18102214.","journal-title":"Int J Mol Sci"},{"issue":"10","key":"6519_CR41","doi-asserted-by":"publisher","first-page":"R453","DOI":"10.1016\/j.cub.2014.03.034","volume":"24","author":"M Schieber","year":"2014","unstructured":"Schieber M, Chandel NS. ROS function in redox signaling and oxidative stress. Curr Biol. 2014;24(10):R453\u201362. https:\/\/doi.org\/10.1016\/j.cub.2014.03.034.","journal-title":"Curr Biol"},{"issue":"7","key":"6519_CR42","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1038\/nrd2803","volume":"8","author":"D Trachootham","year":"2009","unstructured":"Trachootham D, Alexandre J, Huang P. Targeting cancer cells by ROS-mediated mechanisms: A radical therapeutic approach? Nat Rev Drug Discov. 2009;8(7):579\u201391. https:\/\/doi.org\/10.1038\/nrd2803.","journal-title":"Nat Rev Drug Discov"},{"key":"6519_CR43","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1016\/j.freeradbiomed.2017.01.004","volume":"104","author":"S Galadari","year":"2017","unstructured":"Galadari S, Rahman A, Pallichankandy S, Thayyullathil F. Reactive oxygen species and cancer paradox: to promote or to suppress? Free Radic Biol Med. 2017;104:144\u201364. https:\/\/doi.org\/10.1016\/j.freeradbiomed.2017.01.004.","journal-title":"Free Radic Biol Med"},{"issue":"7","key":"6519_CR44","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1093\/aje\/kwr418","volume":"175","author":"AM Leufkens","year":"2012","unstructured":"Leufkens AM, van Duijnhoven FJ, Woudt SH, et al. Biomarkers of oxidative stress and risk of developing colorectal cancer: A cohort-nested case-control study in the European prospective investigation into Cancer and nutrition. Am J Epidemiol. 2012;175(7):653\u201363. https:\/\/doi.org\/10.1093\/aje\/kwr418.","journal-title":"Am J Epidemiol"},{"issue":"3","key":"6519_CR45","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1016\/j.mito.2012.08.002","volume":"13","author":"L Tochhawng","year":"2013","unstructured":"Tochhawng L, Deng S, Pervaiz S, Yap CT. Redox regulation of cancer cell migration and invasion. Mitochondrion. 2013;13(3):246\u201353. https:\/\/doi.org\/10.1016\/j.mito.2012.08.002.","journal-title":"Mitochondrion"},{"issue":"6","key":"6519_CR46","doi-asserted-by":"publisher","first-page":"1777","DOI":"10.1158\/0008-5472.CAN-07-5259","volume":"68","author":"B Kumar","year":"2008","unstructured":"Kumar B, Koul S, Khandrika L, Meacham RB, Koul HK. Oxidative stress is inherent in prostate cancer cells and is required for aggressive phenotype. Cancer Res. 2008;68(6):1777\u201385. https:\/\/doi.org\/10.1158\/0008-5472.CAN-07-5259.","journal-title":"Cancer Res"},{"issue":"6","key":"6519_CR47","doi-asserted-by":"publisher","first-page":"2021","DOI":"10.2353\/ajpath.2007.061144","volume":"171","author":"RS Arnold","year":"2007","unstructured":"Arnold RS, He J, Remo A, et al. Nox1 expression determines cellular reactive oxygen and modulates c-fos-induced growth factor, interleukin-8, and Cav-1. Am J Pathol. 2007;171(6):2021\u201332. https:\/\/doi.org\/10.2353\/ajpath.2007.061144.","journal-title":"Am J Pathol"},{"key":"6519_CR48","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1016\/j.freeradbiomed.2013.07.005","volume":"65","author":"S Antony","year":"2013","unstructured":"Antony S, Wu Y, Hewitt SM, et al. Characterization of NADPH oxidase 5 expression in human tumors and tumor cell lines with a novel mouse monoclonal antibody. Free Radic Biol Med. 2013;65:497\u2013508. https:\/\/doi.org\/10.1016\/j.freeradbiomed.2013.07.005.","journal-title":"Free Radic Biol Med"},{"issue":"5","key":"6519_CR49","doi-asserted-by":"publisher","first-page":"2259","DOI":"10.2353\/ajpath.2010.080747","volume":"176","author":"M Khalili","year":"2010","unstructured":"Khalili M, Mutton LN, Gurel B, et al. Loss of Nkx3.1 expression in bacterial prostatitis: A potential link between inflammation and neoplasia. Am J Pathol. 2010;176(5):2259\u201368. https:\/\/doi.org\/10.2353\/ajpath.2010.080747.","journal-title":"Am J Pathol"},{"issue":"8","key":"6519_CR50","doi-asserted-by":"publisher","first-page":"3089","DOI":"10.1158\/0008-5472.CAN-09-3138","volume":"70","author":"C Bowen","year":"2010","unstructured":"Bowen C, Gelmann EP. NKX3.1 activates cellular response to DNA damage. Cancer Res. 2010;70(8):3089\u201397. https:\/\/doi.org\/10.1158\/0008-5472.CAN-09-3138.","journal-title":"Cancer Res"},{"issue":"3","key":"6519_CR51","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1159\/000342396","volume":"80","author":"T Fujii","year":"2013","unstructured":"Fujii T, Shimada K, Asai O, et al. Immunohistochemical analysis of inflammatory cells in benign and precancerous lesions and carcinoma of the prostate. Pathobiology. 2013;80(3):119\u201326. https:\/\/doi.org\/10.1159\/000342396.","journal-title":"Pathobiology"},{"issue":"9","key":"6519_CR52","doi-asserted-by":"publisher","first-page":"3443","DOI":"10.1073\/pnas.0810473106","volume":"106","author":"KS Sfanos","year":"2009","unstructured":"Sfanos KS, Wilson BA, De Marzo AM, Isaacs WB. Acute inflammatory proteins constitute the organic matrix of prostatic corpora amylacea and calculi in men with prostate cancer. Proc Natl Acad Sci U S A. 2009;106(9):3443\u20138. https:\/\/doi.org\/10.1073\/pnas.0810473106.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"3","key":"6519_CR53","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1016\/j.urology.2004.10.031","volume":"65","author":"B Difuccia","year":"2005","unstructured":"Difuccia B, Keith I, Teunissen B, Moon T. Diagnosis of prostatic inflammation: efficacy of needle biopsies versus tissue blocks. Urology. 2005;65(3):445\u20138. https:\/\/doi.org\/10.1016\/j.urology.2004.10.031.","journal-title":"Urology"},{"key":"6519_CR54","doi-asserted-by":"publisher","first-page":"15651","DOI":"10.1038\/srep15651","volume":"5","author":"M Lundholm","year":"2015","unstructured":"Lundholm M, Hagglof C, Wikberg ML, et al. Secreted factors from colorectal and prostate cancer cells skew the immune response in opposite directions. Sci Rep. 2015;5:15651. https:\/\/doi.org\/10.1038\/srep15651.","journal-title":"Sci Rep"},{"issue":"7693","key":"6519_CR55","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1038\/nature25501","volume":"554","author":"S Mariathasan","year":"2018","unstructured":"Mariathasan S, Turley SJ, Nickles D, et al. TGF\u03b2 attenuates tumour response to PD-L1 Blockade by contributing to exclusion of T cells. Nature. 2018;554(7693):544\u20138. https:\/\/doi.org\/10.1038\/nature25501.","journal-title":"Nature"},{"issue":"23","key":"6519_CR56","doi-asserted-by":"publisher","first-page":"2938","DOI":"10.3748\/wjg.v18.i23.2938","volume":"18","author":"J Yang","year":"2012","unstructured":"Yang J, Zhang JX, Wang H, et al. Hepatocellular carcinoma and macrophage interaction induced tumor immunosuppression via Treg requires TLR4 signaling. World J Gastroenterol. 2012;18(23):2938\u201347. https:\/\/doi.org\/10.3748\/wjg.v18.i23.2938.","journal-title":"World J Gastroenterol"},{"issue":"8","key":"6519_CR57","first-page":"8389","volume":"10","author":"J Wang","year":"2017","unstructured":"Wang J, Huang H, Lu J, et al. Tumor cells induced-M2 macrophage favors accumulation of Treg in nasopharyngeal carcinoma. Int J Clin Exp Pathol. 2017;10(8):8389\u2013401.","journal-title":"Int J Clin Exp Pathol"},{"issue":"5","key":"6519_CR58","doi-asserted-by":"publisher","first-page":"e120631","DOI":"10.1172\/jci.insight.120631","volume":"3","author":"D Gyori","year":"2018","unstructured":"Gyori D, Lim EL, Grant FM, et al. Compensation between CSF1R\u2009+\u2009macrophages and Foxp3\u2009+\u2009Treg cells drives resistance to tumor immunotherapy. JCI Insight. 2018;3(5):e120631. https:\/\/doi.org\/10.1172\/jci.insight.120631.","journal-title":"JCI Insight"},{"issue":"1","key":"6519_CR59","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/s13045-016-0381-z","volume":"10","author":"X Liu","year":"2017","unstructured":"Liu X, Kwon H, Li Z, Fu YX. Is CD47 an innate immune checkpoint for tumor evasion? J Hematol Oncol. 2017;10(1):12. https:\/\/doi.org\/10.1186\/s13045-016-0381-z.","journal-title":"J Hematol Oncol"},{"key":"6519_CR60","doi-asserted-by":"publisher","first-page":"629979","DOI":"10.3389\/fimmu.2021.629979","volume":"12","author":"TOJ Cockram","year":"2021","unstructured":"Cockram TOJ, Dundee JM, Popescu AS, Brown GC. The phagocytic code regulating phagocytosis of mammalian cells. Front Immunol. 2021;12:629979. https:\/\/doi.org\/10.3389\/fimmu.2021.629979.","journal-title":"Front Immunol"},{"key":"6519_CR61","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1146\/annurev-immunol-032713-120142","volume":"32","author":"AN Barclay","year":"2014","unstructured":"Barclay AN, Van den Berg TK. The interaction between signal regulatory protein alpha (SIRP\u03b1) and CD47: structure, function, and therapeutic target. Annu Rev Immunol. 2014;32:25\u201350. https:\/\/doi.org\/10.1146\/annurev-immunol-032713-120142.","journal-title":"Annu Rev Immunol"},{"issue":"2","key":"6519_CR62","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/S1074-7613(00)80089-8","volume":"11","author":"H Nishimura","year":"1999","unstructured":"Nishimura H, Nose M, Hiai H, Minato N, Honjo T. Development of lupus-like autoimmune diseases by disruption of the PD-1 gene encoding an ITIM motif-carrying immunoreceptor. Immunity. 1999;11(2):141\u201351. https:\/\/doi.org\/10.1016\/S1074-7613(00)80089-8.","journal-title":"Immunity"},{"issue":"7","key":"6519_CR63","doi-asserted-by":"publisher","first-page":"1027","DOI":"10.1084\/jem.192.7.1027","volume":"192","author":"GJ Freeman","year":"2000","unstructured":"Freeman GJ, Long AJ, Iwai Y, et al. Engagement of the PD-1 Immunoinhibitory receptor by a novel B7 family member leads to negative regulation of lymphocyte activation. J Exp Med. 2000;192(7):1027\u201334. https:\/\/doi.org\/10.1084\/jem.192.7.1027.","journal-title":"J Exp Med"},{"issue":"4","key":"6519_CR64","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/j.it.2006.02.001","volume":"27","author":"T Okazaki","year":"2006","unstructured":"Okazaki T, Honjo T. The PD-1-PD-L pathway in immunological tolerance. Trends Immunol. 2006;27(4):195\u2013201. https:\/\/doi.org\/10.1016\/j.it.2006.02.001.","journal-title":"Trends Immunol"},{"key":"6519_CR65","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1146\/annurev.immunol.26.021607.090331","volume":"26","author":"ME Keir","year":"2008","unstructured":"Keir ME, Butte MJ, Freeman GJ, Sharpe AH. PD-1 and its ligands in tolerance and immunity. Annu Rev Immunol. 2008;26:677\u2013704. https:\/\/doi.org\/10.1146\/annurev.immunol.26.021607.090331.","journal-title":"Annu Rev Immunol"},{"issue":"7655","key":"6519_CR66","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1038\/nature22396","volume":"545","author":"SR Gordon","year":"2017","unstructured":"Gordon SR, Maute RL, Dulken BW, et al. PD-1 expression by tumour-associated macrophages inhibits phagocytosis and tumour immunity. Nature. 2017;545(7655):495\u20139. https:\/\/doi.org\/10.1038\/nature22396.","journal-title":"Nature"},{"issue":"9","key":"6519_CR67","doi-asserted-by":"publisher","first-page":"1400","DOI":"10.3390\/cancers11091400","volume":"11","author":"NY Sun","year":"2019","unstructured":"Sun NY, Chen YL, Wu WY, et al. Blockade of PD-L1 enhances cancer immunotherapy by regulating dendritic cell maturation and macrophage polarization. Cancers (Basel). 2019;11(9):1400. https:\/\/doi.org\/10.3390\/cancers11091400.","journal-title":"Cancers (Basel)"},{"issue":"4","key":"6519_CR68","doi-asserted-by":"publisher","first-page":"1014","DOI":"10.1016\/j.cell.2018.09.030","volume":"175","author":"MM Gubin","year":"2018","unstructured":"Gubin MM, Esaulova E, Ward JP, et al. High-dimensional analysis delineates myeloid and lymphoid compartment remodeling during successful immune-checkpoint cancer therapy. Cell. 2018;175(4):1014\u2013e103019. https:\/\/doi.org\/10.1016\/j.cell.2018.09.030.","journal-title":"Cell"},{"key":"6519_CR69","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1186\/s13045-019-0760-3","volume":"12","author":"Y Lin","year":"2019","unstructured":"Lin Y, Xu J, Lan H. Tumor-associated macrophages in tumor metastasis: biological roles and clinical therapeutic applications. J Hematol Oncol. 2019;12:76. https:\/\/doi.org\/10.1186\/s13045-019-0760-3.","journal-title":"J Hematol Oncol"},{"key":"6519_CR70","doi-asserted-by":"publisher","first-page":"588941","DOI":"10.3389\/fonc.2020.588941","volume":"10","author":"Z Ge","year":"2020","unstructured":"Ge Z, Ding S. The crosstalk between tumor-associated macrophages (TAMs) and tumor cells and the corresponding targeted therapy. Front Oncol. 2020;10:588941. https:\/\/doi.org\/10.3389\/fonc.2020.588941.","journal-title":"Front Oncol"},{"issue":"7","key":"6519_CR71","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1002\/1878-0261.12095","volume":"11","author":"M Suarez-Carmona","year":"2017","unstructured":"Suarez-Carmona M, Lesage J, Cataldo D, Gilles C. EMT and inflammation: inseparable actors of cancer progression. Mol Oncol. 2017;11(7):805\u201323. https:\/\/doi.org\/10.1002\/1878-0261.12095.","journal-title":"Mol Oncol"},{"key":"6519_CR72","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1186\/1471-2407-12-35","volume":"12","author":"AK Bonde","year":"2012","unstructured":"Bonde AK, Tischler V, Kumar S, et al. Intratumoral macrophages contribute to epithelial-mesenchymal transition in solid tumors. BMC Cancer. 2012;12:35. https:\/\/doi.org\/10.1186\/1471-2407-12-35.","journal-title":"BMC Cancer"},{"issue":"19","key":"6519_CR73","doi-asserted-by":"publisher","first-page":"7022","DOI":"10.1158\/0008-5472.CAN-04-1449","volume":"64","author":"J Wyckoff","year":"2004","unstructured":"Wyckoff J, Wang W, Lin EY, et al. A paracrine loop between tumor cells and macrophages is required for tumor cell migration in mammary tumors. Cancer Res. 2004;64(19):7022\u20139. https:\/\/doi.org\/10.1158\/0008-5472.CAN-04-1449.","journal-title":"Cancer Res"},{"issue":"6","key":"6519_CR74","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1016\/j.ccr.2004.10.026","volume":"6","author":"Q Chen","year":"2004","unstructured":"Chen Q, Zhang XHF, Massagu\u00e9 J. Macrophage binding to receptor VCAM-1 transmits survival signals in breast cancer cells that invade the lungs. Cancer Cell. 2004;6(6):539\u201349. https:\/\/doi.org\/10.1016\/j.ccr.2004.10.026.","journal-title":"Cancer Cell"},{"issue":"8","key":"6519_CR75","doi-asserted-by":"publisher","first-page":"e6562","DOI":"10.1371\/journal.pone.0006562","volume":"4","author":"B Qian","year":"2009","unstructured":"Qian B, Deng Y, Im JH, et al. A distinct macrophage population mediates metastatic breast cancer cell extravasation, establishment and growth. PLoS ONE. 2009;4(8):e6562. https:\/\/doi.org\/10.1371\/journal.pone.0006562.","journal-title":"PLoS ONE"},{"key":"6519_CR76","doi-asserted-by":"publisher","first-page":"67","DOI":"10.3389\/fimmu.2013.00067","volume":"4","author":"GGL Yue","year":"2013","unstructured":"Yue GGL, Chan BCL, Hon PM, et al. Macrophage polarization in prostate cancer progression. Front Immunol. 2013;4:67. https:\/\/doi.org\/10.3389\/fimmu.2013.00067.","journal-title":"Front Immunol"},{"issue":"19","key":"6519_CR77","doi-asserted-by":"publisher","first-page":"1900195","DOI":"10.1002\/advs.201900195","volume":"6","author":"H Kim","year":"2019","unstructured":"Kim H, Chung H, Kim J, et al. Macrophages-triggered sequential remodeling of endothelium-interstitial matrix to form pre-metastatic niche in microfluidic tumor microenvironment. Adv Sci (Weinh). 2019;6(19):1900195. https:\/\/doi.org\/10.1002\/advs.201900195.","journal-title":"Adv Sci (Weinh)"},{"issue":"5","key":"6519_CR78","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1016\/j.chom.2010.10.005","volume":"8","author":"OA Chow","year":"2010","unstructured":"Chow OA, von K\u00f6ckritz-Blickwede M, Bright AT, et al. Statins enhance formation of phagocyte extracellular traps. Cell Host Microbe. 2010;8(5):445\u201354. https:\/\/doi.org\/10.1016\/j.chom.2010.10.005.","journal-title":"Cell Host Microbe"},{"issue":"2","key":"6519_CR79","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1038\/nm.4462","volume":"24","author":"K Okubo","year":"2018","unstructured":"Okubo K, Kurosawa M, Kamiya M, et al. Macrophage extracellular trap formation promoted by platelet activation is a key mediator of rhabdomyolysis-induced acute kidney injury. Nat Med. 2018;24(2):232\u20138. https:\/\/doi.org\/10.1038\/nm.4462.","journal-title":"Nat Med"},{"issue":"2","key":"6519_CR80","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1002\/jlb.59.2.133","volume":"59","author":"M Naito","year":"1996","unstructured":"Naito M, Umeda S, Yamamoto T, et al. Development, differentiation, and phenotypic heterogeneity of murine tissue macrophages. J Leukoc Biol. 1996;59(2):133\u20138. https:\/\/doi.org\/10.1002\/jlb.59.2.133.","journal-title":"J Leukoc Biol"},{"issue":"1","key":"6519_CR81","doi-asserted-by":"publisher","first-page":"12128","DOI":"10.1038\/s41598-017-12474-5","volume":"7","author":"PT King","year":"2017","unstructured":"King PT, Sharma R, O\u2019Sullivan KM, et al. Deoxyribonuclease 1 reduces pathogenic effects of cigarette smoke exposure in the lung. Sci Rep. 2017;7(1):12128. https:\/\/doi.org\/10.1038\/s41598-017-12474-5.","journal-title":"Sci Rep"},{"key":"6519_CR82","doi-asserted-by":"publisher","first-page":"53","DOI":"10.3389\/fcimb.2017.00053","volume":"7","author":"Y An","year":"2017","unstructured":"An Y, Shi X, Tang X, et al. Aflatoxin B1 induces reactive oxygen species-mediated autophagy and extracellular trap formation in macrophages. Front Cell Infect Microbiol. 2017;7:53. https:\/\/doi.org\/10.3389\/fcimb.2017.00053.","journal-title":"Front Cell Infect Microbiol"},{"key":"6519_CR83","doi-asserted-by":"publisher","first-page":"19262","DOI":"10.1038\/srep19262","volume":"6","author":"F Shen","year":"2016","unstructured":"Shen F, Tang X, Cheng W, et al. Fosfomycin enhances phagocyte-mediated killing of Staphylococcus aureus by extracellular traps and reactive oxygen species. Sci Rep. 2016;6:19262. https:\/\/doi.org\/10.1038\/srep19262.","journal-title":"Sci Rep"},{"issue":"6","key":"6519_CR84","doi-asserted-by":"publisher","first-page":"e02084","DOI":"10.1128\/mBio.02084-18","volume":"9","author":"RS Doster","year":"2018","unstructured":"Doster RS, Sutton JA, Rogers LM, Aronoff DM, Gaddy JA. Streptococcus agalactiae induces placental macrophages to release extracellular traps loaded with tissue remodeling enzymes via an oxidative burst-dependent mechanism. mBio. 2018;9(6):e02084\u201318. https:\/\/doi.org\/10.1128\/mBio.02084-18.","journal-title":"mBio"},{"issue":"3","key":"6519_CR85","doi-asserted-by":"publisher","first-page":"e0120371","DOI":"10.1371\/journal.pone.0120371","volume":"10","author":"PT King","year":"2015","unstructured":"King PT, Sharma R, O\u2019Sullivan K, et al. Nontypeable Haemophilus influenzae induces sustained lung oxidative stress and protease expression. PLoS ONE. 2015;10(3):e0120371. https:\/\/doi.org\/10.1371\/journal.pone.0120371.","journal-title":"PLoS ONE"},{"key":"6519_CR86","doi-asserted-by":"publisher","first-page":"67","DOI":"10.3389\/fimmu.2013.00067","volume":"4","author":"S Mohanan","year":"2013","unstructured":"Mohanan S, Horibata S, McElwee JL, Dannenberg AJ, Coonrod SA. Identification of macrophage extracellular trap-like structures in mammary gland adipose tissue: A preliminary study. Front Immunol. 2013;4:67. https:\/\/doi.org\/10.3389\/fimmu.2013.00067.","journal-title":"Front Immunol"},{"key":"6519_CR87","doi-asserted-by":"publisher","first-page":"102297","DOI":"10.1016\/j.jaut.2019.06.008","volume":"105","author":"MEM El Shikh","year":"2019","unstructured":"El Shikh MEM, El Sayed R, Nerviani A, et al. Extracellular traps and PAD4 released by macrophages induce citrullination and auto-antibody production in autoimmune arthritis. J Autoimmun. 2019;105:102297. https:\/\/doi.org\/10.1016\/j.jaut.2019.06.008.","journal-title":"J Autoimmun"},{"key":"6519_CR88","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.freeradbiomed.2018.03.012","volume":"129","author":"BS Rayner","year":"2018","unstructured":"Rayner BS, Zhang Y, Brown BE, et al. Role of hypochlorous acid (HOCl) and other inflammatory mediators in the induction of macrophage extracellular trap formation. Free Radic Biol Med. 2018;129:25\u201334. https:\/\/doi.org\/10.1016\/j.freeradbiomed.2018.03.012.","journal-title":"Free Radic Biol Med"},{"key":"6519_CR89","doi-asserted-by":"publisher","first-page":"577517","DOI":"10.3389\/fimmu.2021.577517","volume":"12","author":"SS Xu","year":"2021","unstructured":"Xu SS, Li H, Li TJ, et al. Neutrophil extracellular traps and macrophage extracellular traps predict postoperative recurrence in resectable nonfunctional pancreatic neuroendocrine tumors. Front Immunol. 2021;12:577517. https:\/\/doi.org\/10.3389\/fimmu.2021.577517.","journal-title":"Front Immunol"},{"issue":"2","key":"6519_CR90","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1215\/S1152851704000781","volume":"7","author":"DJ Brat","year":"2005","unstructured":"Brat DJ, Bellail AC, Van Meir EG. The role of interleukin-8 and its receptors in gliomagenesis and tumoral angiogenesis. Neuro Oncol. 2005;7(2):122\u201333. https:\/\/doi.org\/10.1215\/S1152851704000781.","journal-title":"Neuro Oncol"},{"key":"6519_CR91","doi-asserted-by":"publisher","first-page":"107692","DOI":"10.1016\/j.pharmthera.2020.107692","volume":"219","author":"K Fousek","year":"2021","unstructured":"Fousek K, Horn LA, Palena C. Interleukin-8: A chemokine at the intersection of cancer plasticity, angiogenesis, and immune suppression. Pharmacol Ther. 2021;219:107692. https:\/\/doi.org\/10.1016\/j.pharmthera.2020.107692.","journal-title":"Pharmacol Ther"},{"issue":"2","key":"6519_CR92","doi-asserted-by":"publisher","first-page":"792","DOI":"10.3390\/ijms23020792","volume":"23","author":"J Korbecki","year":"2022","unstructured":"Korbecki J, Barczak K, Gutowska I, et al. CXCL1: gene, promoter, regulation of expression, mRNA stability, regulation of activity in the intercellular space. Int J Mol Sci. 2022;23(2):792. https:\/\/doi.org\/10.3390\/ijms23020792.","journal-title":"Int J Mol Sci"},{"issue":"1","key":"6519_CR93","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/j.cyto.2012.04.013","volume":"59","author":"Y Wang","year":"2012","unstructured":"Wang Y, Li L, Guo X, et al. Interleukin-8 secretion by ovarian cancer cells increases anchorage-independent growth, proliferation, angiogenic potential, adhesion and invasion. Cytokine. 2012;59(1):145\u201355. https:\/\/doi.org\/10.1016\/j.cyto.2012.04.013.","journal-title":"Cytokine"},{"issue":"17","key":"6519_CR94","doi-asserted-by":"publisher","first-page":"4495","DOI":"10.3390\/cancers13174495","volume":"13","author":"U Demkow","year":"2021","unstructured":"Demkow U. Neutrophil extracellular traps (NETs) in cancer invasion, evasion and metastasis. Cancers (Basel). 2021;13(17):4495. https:\/\/doi.org\/10.3390\/cancers13174495.","journal-title":"Cancers (Basel)"},{"key":"6519_CR95","doi-asserted-by":"publisher","first-page":"67","DOI":"10.3389\/fimmu.2013.00067","volume":"4","author":"S Mohanan","year":"2013","unstructured":"Mohanan S, Horibata S, McElwee JL, et al. Identification of macrophage extracellular trap-like structures in mammary gland adipose tissue: A preliminary study. Front Immunol. 2013;4:67. https:\/\/doi.org\/10.3389\/fimmu.2013.00067.","journal-title":"Front Immunol"},{"key":"6519_CR96","doi-asserted-by":"publisher","first-page":"779325","DOI":"10.3389\/fimmu.2021.779325","volume":"12","author":"T Chen","year":"2021","unstructured":"Chen T, Wang Y, Nan Z, et al. Interaction between macrophage extracellular traps and colon cancer cells promotes colon cancer invasion and correlates with unfavorable prognosis. Front Immunol. 2021;12:779325. https:\/\/doi.org\/10.3389\/fimmu.2021.779325.","journal-title":"Front Immunol"},{"issue":"1","key":"6519_CR97","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1200\/JCO.2016.69.1584","volume":"35","author":"TM Beer","year":"2017","unstructured":"Beer TM, Kwon ED, Drake CG, et al. Randomized, double-blind, phase III trial of ipilimumab versus placebo in asymptomatic or minimally symptomatic patients with metastatic chemotherapy-naive castration-resistant prostate cancer. J Clin Oncol. 2017;35(1):40\u20137. https:\/\/doi.org\/10.1200\/JCO.2016.69.1584.","journal-title":"J Clin Oncol"},{"issue":"11","key":"6519_CR98","doi-asserted-by":"publisher","first-page":"e1644109","DOI":"10.1080\/2162402X.2019.1644109","volume":"8","author":"H Taghizadeh","year":"2019","unstructured":"Taghizadeh H, Marhold M, Tomasich E, et al. Immune checkpoint inhibitors in mCRPC - rationales, challenges and perspectives. Oncoimmunology. 2019;8(11):e1644109. https:\/\/doi.org\/10.1080\/2162402X.2019.1644109.","journal-title":"Oncoimmunology"},{"key":"6519_CR99","doi-asserted-by":"publisher","first-page":"994019","DOI":"10.3389\/fimmu.2022.994019","volume":"13","author":"X Qu","year":"2022","unstructured":"Qu X, Zhao X, Lin K, et al. M2-like tumor-associated macrophage-related biomarkers to construct a novel prognostic signature, reveal the immune landscape, and screen drugs in hepatocellular carcinoma. Front Immunol. 2022;13:994019. https:\/\/doi.org\/10.3389\/fimmu.2022.994019.","journal-title":"Front Immunol"},{"issue":"19","key":"6519_CR100","doi-asserted-by":"publisher","first-page":"2423","DOI":"10.1038\/onc.2013.191","volume":"33","author":"G Comito","year":"2014","unstructured":"Comito G, Giannoni E, Segura CP, et al. Cancer-associated fibroblasts and M2-polarized macrophages synergize during prostate carcinoma progression. Oncogene. 2014;33(19):2423\u201331. https:\/\/doi.org\/10.1038\/onc.2013.191.","journal-title":"Oncogene"},{"issue":"11","key":"6519_CR101","doi-asserted-by":"publisher","first-page":"1464","DOI":"10.1016\/j.ccell.2021.09.005","volume":"39","author":"Y Kfoury","year":"2021","unstructured":"Kfoury Y, Baryawno N, Severe N, et al. Human prostate cancer bone metastases have an actionable immunosuppressive microenvironment. Cancer Cell. 2021;39(11):1464\u2013e14788. https:\/\/doi.org\/10.1016\/j.ccell.2021.09.005.","journal-title":"Cancer Cell"},{"issue":"2","key":"6519_CR102","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.prnil.2020.02.001","volume":"8","author":"P Yuri","year":"2020","unstructured":"Yuri P, Shigemura K, Kitagawa K, et al. Increased tumor-associated macrophages in the prostate cancer microenvironment predicted patients\u2019 survival and responses to androgen deprivation therapies in Indonesian patients cohort. Prostate Int. 2020;8(2):62\u20139. https:\/\/doi.org\/10.1016\/j.prnil.2020.02.001.","journal-title":"Prostate Int"},{"key":"6519_CR103","doi-asserted-by":"publisher","first-page":"756722","DOI":"10.3389\/fimmu.2021.756722","volume":"12","author":"Q Yang","year":"2021","unstructured":"Yang Q, Zhang H, Wei T, et al. Single-cell RNA sequencing reveals the heterogeneity of tumor-associated macrophage in non-small cell lung cancer and differences between sexes. Front Immunol. 2021;12:756722. https:\/\/doi.org\/10.3389\/fimmu.2021.756722.","journal-title":"Front Immunol"},{"issue":"2","key":"6519_CR104","doi-asserted-by":"publisher","first-page":"e1584","DOI":"10.1002\/ctm2.1584","volume":"14","author":"JS Isenberg","year":"2024","unstructured":"Isenberg JS, Montero E. Tolerating CD47. Clin Transl Med. 2024;14(2):e1584. https:\/\/doi.org\/10.1002\/ctm2.1584.","journal-title":"Clin Transl Med"},{"issue":"16","key":"6519_CR105","doi-asserted-by":"publisher","first-page":"1784","DOI":"10.1016\/j.lfs.2005.08.019","volume":"78","author":"T Engl","year":"2006","unstructured":"Engl T, Relja B, Blumenberg C, et al. Prostate tumor CXC-chemokine profile correlates with cell adhesion to endothelium and extracellular matrix. Life Sci. 2006;78(16):1784\u201393. https:\/\/doi.org\/10.1016\/j.lfs.2005.08.019.","journal-title":"Life Sci"},{"issue":"50","key":"6519_CR106","doi-asserted-by":"publisher","first-page":"87891","DOI":"10.18632\/oncotarget.21248","volume":"8","author":"M Tripathi","year":"2017","unstructured":"Tripathi M, Nandana S, Billet S, et al. Modulation of Cabozantinib efficacy by the prostate tumor microenvironment. Oncotarget. 2017;8(50):87891\u2013902. https:\/\/doi.org\/10.18632\/oncotarget.21248.","journal-title":"Oncotarget"},{"key":"6519_CR107","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1186\/s12967-014-0294-y","volume":"12","author":"AR Kwilas","year":"2014","unstructured":"Kwilas AR, Ardiani A, Donahue RN, et al. Dual effects of a targeted small-molecule inhibitor (cabozantinib) on immune-mediated killing of tumor cells and immune tumor microenvironment permissiveness when combined with a cancer vaccine. J Transl Med. 2014;12:294. https:\/\/doi.org\/10.1186\/s12967-014-0294-y.","journal-title":"J Transl Med"},{"issue":"7647","key":"6519_CR108","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1038\/nature21676","volume":"543","author":"X Lu","year":"2017","unstructured":"Lu X, Horner JW, Paul E, et al. Effective combinatorial immunotherapy for castration-resistant prostate cancer. Nature. 2017;543(7647):728\u201332. https:\/\/doi.org\/10.1038\/nature21676.","journal-title":"Nature"},{"key":"6519_CR109","doi-asserted-by":"publisher","first-page":"e77974","DOI":"10.7554\/eLife.77974","volume":"11","author":"LK Krasniewski","year":"2022","unstructured":"Krasniewski LK, Chakraborty P, Cui CY, et al. Single-cell analysis of skeletal muscle macrophages reveals age-associated functional subpopulations. Elife. 2022;11:e77974. https:\/\/doi.org\/10.7554\/eLife.77974.","journal-title":"Elife"},{"issue":"15","key":"6519_CR110","doi-asserted-by":"publisher","first-page":"e166248","DOI":"10.1172\/JCI166248","volume":"133","author":"G Gritsina","year":"2023","unstructured":"Gritsina G, Fong KW, Lu X, et al. Chemokine receptor CXCR7 activates Aurora kinase A and promotes neuroendocrine prostate cancer growth. J Clin Invest. 2023;133(15):e166248. https:\/\/doi.org\/10.1172\/JCI166248.","journal-title":"J Clin Invest"},{"issue":"1","key":"6519_CR111","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1172\/JCI92466","volume":"128","author":"H Roca","year":"2018","unstructured":"Roca H, Jones JD, Purica MC, et al. Apoptosis-induced CXCL5 accelerates inflammation and growth of prostate tumor metastases in bone. J Clin Invest. 2018;128(1):248\u201366. https:\/\/doi.org\/10.1172\/JCI92466.","journal-title":"J Clin Invest"},{"issue":"1","key":"6519_CR112","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1042\/BST20210962","volume":"50","author":"KH Rasmussen","year":"2022","unstructured":"Rasmussen KH, Hawkins CL. Role of macrophage extracellular traps in innate immunity and inflammatory disease. Biochem Soc Trans. 2022;50(1):21\u201332. https:\/\/doi.org\/10.1042\/BST20210962.","journal-title":"Biochem Soc Trans"},{"issue":"1","key":"6519_CR113","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1186\/s40425-018-0452-5","volume":"6","author":"ZF Wen","year":"2018","unstructured":"Wen ZF, Liu H, Gao R, et al. Tumor cell-released autophagosomes (TRAPs) promote immunosuppression through induction of M2-like macrophages with increased expression of PD-L1. J Immunother Cancer. 2018;6(1):151. https:\/\/doi.org\/10.1186\/s40425-018-0452-5.","journal-title":"J Immunother Cancer"},{"key":"6519_CR114","doi-asserted-by":"publisher","first-page":"874589","DOI":"10.3389\/fimmu.2022.874589","volume":"13","author":"Y Pu","year":"2022","unstructured":"Pu Y, Ji Q. Tumor-associated macrophages regulate PD-1\/PD-L1 immunosuppression. Front Immunol. 2022;13:874589. https:\/\/doi.org\/10.3389\/fimmu.2022.874589.","journal-title":"Front Immunol"},{"issue":"7930","key":"6519_CR115","doi-asserted-by":"publisher","first-page":"1207","DOI":"10.1038\/s41586-024-08290-3","volume":"637","author":"A Lyu","year":"2025","unstructured":"Lyu A, Fan Z, Clark M, et al. Evolution of myeloid-mediated immunotherapy resistance in prostate cancer. Nature. 2025;637(7930):1207\u201317. https:\/\/doi.org\/10.1038\/s41586-024-08290-3.","journal-title":"Nature"},{"issue":"1","key":"6519_CR116","doi-asserted-by":"publisher","first-page":"445","DOI":"10.18632\/aging.205378","volume":"16","author":"J Wang","year":"2024","unstructured":"Wang J, Wu W, Yuan T, et al. Tumor-associated macrophages and PD-L1 in prostate cancer: A possible key to unlocking immunotherapy efficacy. Aging. 2024;16(1):445\u201365. https:\/\/doi.org\/10.18632\/aging.205378.","journal-title":"Aging"},{"issue":"2","key":"6519_CR117","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1016\/j.coi.2012.01.010","volume":"24","author":"MP Chao","year":"2012","unstructured":"Chao MP, Weissman IL, Majeti R. The CD47-SIRP\u03b1 pathway in cancer immune evasion and potential therapeutic implications. Curr Opin Immunol. 2012;24(2):225\u201332. https:\/\/doi.org\/10.1016\/j.coi.2012.01.010.","journal-title":"Curr Opin Immunol"},{"issue":"3","key":"6519_CR118","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1016\/S0962-8924(00)01906-1","volume":"11","author":"EJ Brown","year":"2001","unstructured":"Brown EJ, Frazier WA. Integrin-associated protein (CD47) and its ligands. Trends Cell Biol. 2001;11(3):130\u20135. https:\/\/doi.org\/10.1016\/S0962-8924(00)01906-1.","journal-title":"Trends Cell Biol"},{"issue":"11","key":"6519_CR119","doi-asserted-by":"publisher","first-page":"1051","DOI":"10.1007\/s12094-016-1489-x","volume":"18","author":"F Kong","year":"2016","unstructured":"Kong F, Gao F, Li H, et al. CD47: A potential immunotherapy target for eliminating cancer cells. Clin Transl Oncol. 2016;18(11):1051\u20135. https:\/\/doi.org\/10.1007\/s12094-016-1489-x.","journal-title":"Clin Transl Oncol"},{"issue":"7","key":"6519_CR120","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1016\/j.leukres.2015.04.007","volume":"39","author":"S Galli","year":"2015","unstructured":"Galli S, Zlobec I, Sch\u00fcrch C, et al. CD47 protein expression in acute myeloid leukemia: A tissue microarray-based analysis. Leuk Res. 2015;39(7):749\u201356. https:\/\/doi.org\/10.1016\/j.leukres.2015.04.007.","journal-title":"Leuk Res"},{"key":"6519_CR121","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/j.biopha.2015.05.017","volume":"73","author":"Q Chen","year":"2015","unstructured":"Chen Q, Fang X, Jiang C, et al. Thrombospondin promoted anti-tumor of adenovirus-mediated calreticulin in breast cancer: relationship with anti-CD47. Biomed Pharmacother. 2015;73:109\u201315. https:\/\/doi.org\/10.1016\/j.biopha.2015.05.017.","journal-title":"Biomed Pharmacother"},{"issue":"7","key":"6519_CR122","doi-asserted-by":"publisher","first-page":"2610","DOI":"10.1172\/JCI81603","volume":"126","author":"K Weiskopf","year":"2016","unstructured":"Weiskopf K, Jahchan NS, Schnorr PJ, et al. CD47-blocking immunotherapies stimulate macrophage-mediated destruction of small-cell lung cancer. J Clin Invest. 2016;126(7):2610\u201320. https:\/\/doi.org\/10.1172\/JCI81603.","journal-title":"J Clin Invest"},{"issue":"52","key":"6519_CR123","doi-asserted-by":"publisher","first-page":"31113","DOI":"10.1074\/jbc.M115.682914","volume":"290","author":"JD Londino","year":"2015","unstructured":"Londino JD, Gulick D, Isenberg JS, Mallampalli RK. Cleavage of signal regulatory protein \u03b1 (SIRP\u03b1) enhances inflammatory signaling. J Biol Chem. 2015;290(52):31113\u201325. https:\/\/doi.org\/10.1074\/jbc.M115.682914.","journal-title":"J Biol Chem"},{"issue":"12","key":"6519_CR124","doi-asserted-by":"publisher","first-page":"eaam6202","DOI":"10.1126\/sciimmunol.aam6202","volume":"2","author":"H Dai","year":"2017","unstructured":"Dai H, Friday AJ, Abou-Daya KI, et al. Donor SIRP\u03b1 polymorphism modulates the innate immune response to allogeneic grafts. Sci Immunol. 2017;2(12):eaam6202. https:\/\/doi.org\/10.1126\/sciimmunol.aam6202.","journal-title":"Sci Immunol"},{"issue":"4","key":"6519_CR125","doi-asserted-by":"publisher","first-page":"e0153550","DOI":"10.1371\/journal.pone.0153550","volume":"11","author":"M Zhang","year":"2016","unstructured":"Zhang M, Hutter G, Kahn SA, et al. Anti-CD47 treatment stimulates phagocytosis of glioblastoma by M1 and M2 polarized macrophages and promotes M1 polarized macrophages in vivo. PLoS ONE. 2016;11(4):e0153550. https:\/\/doi.org\/10.1371\/journal.pone.0153550.","journal-title":"PLoS ONE"},{"issue":"1","key":"6519_CR126","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1038\/s41590-017-0004-z","volume":"19","author":"AA Barkal","year":"2018","unstructured":"Barkal AA, Weiskopf K, Kao KS, et al. Engagement of MHC class I by the inhibitory receptor LILRB1 suppresses macrophages and is a target of cancer immunotherapy. Nat Immunol. 2018;19(1):76\u201384. https:\/\/doi.org\/10.1038\/s41590-017-0004-z.","journal-title":"Nat Immunol"},{"issue":"6","key":"6519_CR127","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1016\/S0092-8674(02)00971-6","volume":"110","author":"RO Hynes","year":"2002","unstructured":"Hynes RO, Integrins. Bidirectional, allosteric signaling machines. Cell. 2002;110(6):673\u201387. https:\/\/doi.org\/10.1016\/S0092-8674(02)00971-6.","journal-title":"Cell"},{"issue":"3","key":"6519_CR128","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1002\/jcp.21237","volume":"213","author":"AL Berrier","year":"2007","unstructured":"Berrier AL, Yamada KM. Cell-matrix adhesion. J Cell Physiol. 2007;213(3):565\u201373. https:\/\/doi.org\/10.1002\/jcp.21237.","journal-title":"J Cell Physiol"},{"issue":"12","key":"6519_CR129","doi-asserted-by":"publisher","first-page":"2966","DOI":"10.1161\/ATVBAHA.112.300031","volume":"32","author":"G Cs\u00e1nyi","year":"2012","unstructured":"Cs\u00e1nyi G, Yao M, Rodr\u00edguez AI, et al. Thrombospondin-1 regulates blood flow via CD47 receptor-mediated activation of NADPH oxidase 1. Arterioscler Thromb Vasc Biol. 2012;32(12):2966\u201373. https:\/\/doi.org\/10.1161\/ATVBAHA.112.300031.","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"2","key":"6519_CR130","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1016\/j.kint.2016.03.034","volume":"90","author":"NM Rogers","year":"2016","unstructured":"Rogers NM, Zhang ZJ, Wang JJ, Thomson AW, Isenberg JS. CD47 regulates renal tubular epithelial cell self-renewal and proliferation following renal ischemia reperfusion. Kidney Int. 2016;90(2):334\u201347. https:\/\/doi.org\/10.1016\/j.kint.2016.03.034.","journal-title":"Kidney Int"},{"key":"6519_CR131","doi-asserted-by":"publisher","unstructured":"Yao M, Rogers NM, Cs\u00e1nyi G et al. Thrombospondin-1 activation of signal-regulatory protein-\u03b1 stimulates reactive oxygen species production and promotes renal ischemia reperfusion injury [published correction appears in J Am Soc Nephrol. 2014;25(8):1884]. J Am Soc Nephrol. 2014;25(6):1171\u20131186. https:\/\/doi.org\/10.1681\/ASN.2013040433","DOI":"10.1681\/ASN.2013040433"},{"key":"6519_CR132","doi-asserted-by":"publisher","first-page":"1673","DOI":"10.1038\/srep01673","volume":"3","author":"S Kaur","year":"2013","unstructured":"Kaur S, Soto-Pantoja DR, Stein EV, et al. Thrombospondin-1 signaling through CD47 inhibits self-renewal by regulating c-Myc and other stem cell transcription factors. Sci Rep. 2013;3:1673. https:\/\/doi.org\/10.1038\/srep01673.","journal-title":"Sci Rep"},{"issue":"3","key":"6519_CR133","doi-asserted-by":"publisher","first-page":"212","DOI":"10.3109\/10409238.2015.1014024","volume":"50","author":"DR Soto-Pantoja","year":"2015","unstructured":"Soto-Pantoja DR, Kaur S, Roberts DD. CD47 signaling pathways controlling cellular differentiation and responses to stress. Crit Rev Biochem Mol Biol. 2015;50(3):212\u201330. https:\/\/doi.org\/10.3109\/10409238.2015.1014024.","journal-title":"Crit Rev Biochem Mol Biol"},{"issue":"11","key":"6519_CR134","doi-asserted-by":"publisher","first-page":"1972","DOI":"10.1016\/j.ccell.2023.10.006","volume":"41","author":"JE Hawley","year":"2023","unstructured":"Hawley JE, Obradovic AZ, Dallos MC, et al. Anti-PD-1 immunotherapy with androgen deprivation therapy induces robust immune infiltration in metastatic castration-sensitive prostate cancer. Cancer Cell. 2023;41(11):1972\u2013e19885. https:\/\/doi.org\/10.1016\/j.ccell.2023.10.006.","journal-title":"Cancer Cell"},{"issue":"7","key":"6519_CR135","doi-asserted-by":"publisher","first-page":"750","DOI":"10.1158\/2159-8290.CD-16-0778","volume":"7","author":"A Patnaik","year":"2017","unstructured":"Patnaik A, Swanson KD, Csizmadia E, et al. Cabozantinib eradicates advanced murine prostate cancer by activating antitumor innate immunity. Cancer Discov. 2017;7(7):750\u201365. https:\/\/doi.org\/10.1158\/2159-8290.CD-16-0778.","journal-title":"Cancer Discov"},{"issue":"6","key":"6519_CR136","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1038\/nrurol.2017.50","volume":"14","author":"P Sidaway","year":"2017","unstructured":"Sidaway P. Prostate cancer: Cabozantinib activates innate immunity. Nat Rev Urol. 2017;14(6):327. https:\/\/doi.org\/10.1038\/nrurol.2017.50.","journal-title":"Nat Rev Urol"},{"issue":"2","key":"6519_CR137","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1016\/j.eururo.2015.02.032","volume":"68","author":"ED Carosella","year":"2015","unstructured":"Carosella ED, Ploussard G, LeMaoult J, Desgrandchamps F. A systematic review of immunotherapy in urologic cancer: evolving roles for targeting of CTLA-4, PD-1\/PD-L1, and HLA-G. Eur Urol. 2015;68(2):267\u201379. https:\/\/doi.org\/10.1016\/j.eururo.2015.02.032.","journal-title":"Eur Urol"},{"issue":"5","key":"6519_CR138","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1038\/nm.4308","volume":"23","author":"J Gao","year":"2017","unstructured":"Gao J, Ward JF, Pettaway CA, et al. VISTA is an inhibitory immune checkpoint that is increased after ipilimumab therapy in patients with prostate cancer. Nat Med. 2017;23(5):551\u20135. https:\/\/doi.org\/10.1038\/nm.4308.","journal-title":"Nat Med"},{"issue":"8","key":"6519_CR139","doi-asserted-by":"publisher","first-page":"947","DOI":"10.1038\/s41587-020-0462-y","volume":"38","author":"M Klichinsky","year":"2020","unstructured":"Klichinsky M, Ruella M, Shestova O, et al. Human chimeric antigen receptor macrophages for cancer immunotherapy. Nat Biotechnol. 2020;38(8):947\u201353. https:\/\/doi.org\/10.1038\/s41587-020-0462-y.","journal-title":"Nat Biotechnol"}],"container-title":["Journal of Translational Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-025-06519-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12967-025-06519-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-025-06519-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,2]],"date-time":"2025-06-02T13:15:14Z","timestamp":1748870114000},"score":1,"resource":{"primary":{"URL":"https:\/\/translational-medicine.biomedcentral.com\/articles\/10.1186\/s12967-025-06519-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,2]]},"references-count":139,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["6519"],"URL":"https:\/\/doi.org\/10.1186\/s12967-025-06519-x","relation":{},"ISSN":["1479-5876"],"issn-type":[{"value":"1479-5876","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,2]]},"assertion":[{"value":"22 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 April 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 June 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Clinical Trial Number"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"615"}}